AHSG and chronic kidney disease: For example, (i) non-CKD models, such as genetically modified mice expressing less calcification inhibitors (i.e., fetuin-A, MGP), and rats receiving high dosages of warfarin and (ii) CKD-related models, including rats undergoing 5/6th nephrectomy or receiving an adenine diet, both combined with high phosphate intake [162,163].